Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

    NEXT STORY
    Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine
    PREV STORY
    Odiparcil development advances with recruitment of first patients in a new biomarker study in MPS VI children and adults
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    India Medical Plastics Market Size, Share & Trends Analysis Report By Product, By Application And Segment Forecasts, 2020 – 2030

    author_avatar
    NASDAQ Market News

    New Clinical and Biomarker Data Validate Immune Design’s Lead Programs and Discovery Platforms

    Data from CMB305 and G100 to be Presented at ASCO Annual Meeting in June ...

    author_avatar
    NASDAQ Market News

    pMD Announces Instant Capture for Lighting Fast Mobile Charge Capture in Seconds

    author_avatar
    NASDAQ Market News